Testing effectiveness (Phase 2)Ended earlyNCT00271011What this trial is testingMitomycin C, Irinotecan, and CetuximabWho this might be right forColorectal Cancer University of Michigan Rogel Cancer Center 13
Not applicableLooking for participantsNCT06208397What this trial is testingMRE for Assessment of Histopathological Growth Patterns in Colorectal Liver MetastasesWho this might be right forMetastatic Colorectal Cancer Shengjing Hospital 50
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Not applicableStudy completedNCT06048146What this trial is testingA Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node MetastasisWho this might be right forLymph Node MetastasisCancer of Rectum and AnusOxaliplatin+4 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Testing effectiveness (Phase 2)Study completedNCT01807546What this trial is testingOral Rigosertib for Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more Traws Pharma, Inc. 64
Not applicableWithdrawnNCT01847495What this trial is testingEvaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver MetastasisWho this might be right forColorectal Cancer Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00988936What this trial is testingEfficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic DrugWho this might be right forMetastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Ended earlyNCT01523639What this trial is testingA Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated SteatosisWho this might be right forColorectal CancerSteatohepatitis Austrian Breast & Colorectal Cancer Study Group 8
Testing effectiveness (Phase 2)Study completedNCT01394939What this trial is testingRecombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaWho this might be right forColorectal CarcinomaCRC Jennerex Biotherapeutics 52
Testing effectiveness (Phase 2)Looking for participantsNCT05913674What this trial is testingTechnical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)Who this might be right forPeritoneal CarcinomatosisAppendiceal NeoplasmsColorectal Cancer Metastatic Ciusss de L'Est de l'Île de Montréal 25
Not applicableStudy completedNCT02547480What this trial is testingLifePearl-Iri Pharmacokinetic StudyWho this might be right forMetastatic Colorectal CancermCRC Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Study completedNCT00083720What this trial is testingErbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyWho this might be right forColorectal NeoplasmsMetastasesNeoplasm Eli Lilly and Company 87
Testing effectiveness (Phase 2)Looking for participantsNCT06445062What this trial is testingStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsWho this might be right forColorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)WithdrawnNCT03307603What this trial is testingYttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT02732860What this trial is testingPersonalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostWho this might be right forColorectal NeoplasmsColorectal CancerBreast Cancer+3 more University Health Network, Toronto 120
Not applicableUnknownNCT03852290What this trial is testingC677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon CancerWho this might be right forColon CancerMTHFR Gene MutationChemotherapeutic Toxicity+1 more Universidad de Costa Rica 65
Not applicableStudy completedNCT01089413What this trial is testingObservational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)Who this might be right forColorectal Cancer Hoffmann-La Roche 201
Not applicableActive Not RecruitingNCT03908788What this trial is testingDetection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) TherapyWho this might be right forMetastatic Colorectal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 130
Testing effectiveness (Phase 2)Study completedNCT00460603What this trial is testingStudy With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Pfizer 187